AndresCCP escribió: ↑Jue May 09, 2019 1:43 am Por si a alguien le interesa, acá un abstract de un estudio doble-ciego en mujeres con efluvio telógeno, recientemente publicado. Nótese que se usa una concentración de 1% por un período de 6 meses.Buenas;
Saludos a todos.
https://www.jidonline.org/article/S0022 ... 0/fulltext
"Human hair follicles (HFs) express the olfactory receptor OR2AT4, whose specific stimulation by the synthetic sandalwood-like odorant, Sandalore®, prolongs anagen ex vivo. To study whether this effect of Sandalore® is clinically relevant, we conducted a randomized, double-blinded, placebo-controlled, prospective clinical trial involving 60 female volunteers affected by telogen effluvium with a defined, substantial degree of hair shedding. Patients were treated topically with a solution containing either 1% Sandalore® (verum) or natural sandalwood oil (placebo), which has the same odor as Sandalore® but does not stimulate OR2AT4, over a period of 24 weeks. Sandalore® 1% ameliorated clinical signs of telogen effluvium, namely it reduced hair shedding, increased hair volume and increased the percentage of anagen HFs over time significantly more than placebo, and showed a trend towards increasing the ratio of terminal/vellus hairs. Hair shaft thickness and density were not affected. Most of the anti-hair shedding effects were seen already after 8 weeks and maintained at week 24. Subjectively, individuals in the treatment group were “more satisfied” than in the placebo group regarding hair appearance and overall results. This clinical trial confirmed the anagen-maintaining effects of Sandalore® seen ex vivo and provides the first evidence that a cosmetic odorant can positively impact on human hair growth in vivo, encouraging the use of topical “olfactotherapy” with Sandalore® as adjunct therapy of hair disorders characterized by excessive hair shedding."
Entonces ya puedo ir tirando mis pócimas al 0,2 %? jaja
Un saludo y good luck
